Tilray Brands 株価情報 (NASDAQ: TLRY)

最新ニュース Tilray Brands (NASDAQ:TLRY) 株価情報

Tilray Brands

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.

Tilray Brands Inc

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/BMMJ">Body and Mind</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BMMJ#OTC">BMMJ</a>) shares closed up 6900.00% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed up 70.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed up 20.90% at $1.66</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed up 20.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed up 11.20% at $0.49</li>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed up 9.43% at $1.04</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed up 6.67% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed up 5.77% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed up 5.55% at $7.34</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed up 4.39% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed up 3.53% at $0.38</li>
<li><a href="https://www.benzinga.com/quote/ACB">Aurora Cannabis</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares closed up 3.44% at $5.13</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 13.04% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed down 11.11% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">FLUENT</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed down 10.89% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 9.38% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed down 7.63% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/CBWTF">Auxly Cannabis Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTC">CBWTF</a>) shares closed down 6.59% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/CURLF">Curaleaf Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed down 5.66% at $0.83</li>
<li><a href="https://www.benzinga.com/quote/CRLBF">Cresco Labs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed down 5.36% at $0.68</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed down 4.33% at $4.46</li>
<li><a href="https://www.benzinga.com/quote/YCBD">cbdMD</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed down 4.04% at $0.95</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cannabis

Markets

Movers

BMMJ

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

CLSH

CNBX

CNTMF

CRBP

CRLBF

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

CVSI

FFNTF

FUAPF

GNLN

KAYS

LEAFBUYER TECHNOLOGIES by Leafbuyer Technologies, Inc.

LBUY

RMHB

TCNNF

TLRY

UGRO

YCBD

Cannabis Stock Movers For May 16, 2025

Tilray Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares are trading relatively flat in <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">the premarket session on Wednesday</a>.
The firm has announced a product line expansion through its subsidiary, High Park Holdings Ltd., entering deeper into <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/g45402188/tilray-brands-announces-the-launch-of-xmg-atomic-sours-new-thc-beverages-and-edibles" rel="noreferrer noopener">Canada's cannabis-infused consumer market.</a>
The launch of XMG Atomic Sours, a new lineup of sour-flavored cannabis drinks and gummies, is the latest move in Tilray's bid to diversify its product portfolio and tap into emerging customer preferences.
Tilray said that the XMG Atomic Sours beverages is available nationwide via select retailers.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/cannabis/25/05/45297889/germanys-cannabis-industry-hits-e500m-2500-pharmacies-now-dispense-211-grow-clubs-approved" rel="noreferrer noopener">Germany&#8217;s Cannabis Industry Hits 500 Million Euros: 2,500 Pharmacies Now Dispense, 211 Grow Clubs Approved</a>
It includes the flavors Cherry Blasted Lime and Foggy Peaches. Each 355ml drink includes 10mg of THC, 10mg of CBG, and a caffeine content of 30mg sourced from guarana extract.
According to the company, the beverages utilize nano-emulsified THCA diamonds to speed up onset time, aligning with demand for fast-acting cannabis products.
The XMG Atomic Sours Gummies represent High Park's entry into the cannabis edibles space.
Plant-based pectin is used in place of gelatin, and the gummies are shaped like keys—a nostalgic nod aimed at invoking flavor memories. The company describes the flavor experience as "intensely sour."
This apart, the company continues to grow its cannabis and beverage offerings in North America and recently saw the return of its Blue Point Brewing Co. Delayed Pilsner—targeted at the New York commuting crowd—<a target="_blank" href="https://www.benzinga.com/25/05/45233132/whats-going-on-with-tilray-brands-stock-on-tuesday]" rel="noreferrer noopener">back on shelves earlier this month</a>.
The brand expansion aligns with Tilray's long-term strategy to compete across multiple cannabis consumption categories.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, TLRY stock has lost over 78% in the past year. Investors can gain exposure to the stock via AdvisorShares Pure Cannabis ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YOLO#NYSE">YOLO</a>).
Price Action: TLRY shares are trading higher by 0.09% to $0.4508 premarket at last check Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cannabis/25/04/45011379/why-cannabis-stocks-jumped-by-double-digits-and-why-analysts-say-dont-drink-the-kool-aid-in-one-gulp" target="_blank" rel="noreferrer noopener">Why Cannabis Stocks Jumped By Double Digits And Why Analysts Say &#8216;Don&#8217;t Drink The Kool-Aid In One Gulp&#8217;</a></li>
</ul>
Photo: Shutterstock

Equities

News

General

YOLO

What's Going On With Tilray Brands Stock On Wednesday?

Tilray Subsidiary High Park Launches XMG Atomic Sours Line Of Cannabis Beverages And Gummies With 'Nostalgic Sour Flavours'

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/FLOOF">Flower One Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FLOOF#OTC">FLOOF</a>) shares closed up 9900.00% at $0.0001</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed up 17.65% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">FLUENT</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed up 13.05% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed up 9.92% at $1.46</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed up 9.92% at $7.16</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed up 8.46% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed up 7.69% at $1.12</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed up 7.50% at $0.46</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed up 6.25% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed up 5.69% at $1.07</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed up 5.58% at $57.00</li>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed up 5.22% at $0.70</li>
<li><a href="https://www.benzinga.com/quote/ACB">Aurora Cannabis</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares closed up 4.33% at $5.06</li>
<li><a href="https://www.benzinga.com/quote/OGI">Organigram Global</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) shares closed up 4.24% at $1.28</li>
<li><a href="https://www.benzinga.com/quote/SOL">Emeren Group</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed up 3.38% at $1.52</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/ALEAF">Aleafia Health</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ALEAF#OTC">ALEAF</a>) shares closed down 99.00% at $1e-06</li>
<li><a href="https://www.benzinga.com/quote/BMMJ">Body and Mind</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BMMJ#OTC">BMMJ</a>) shares closed down 98.72% at $0.0001</li>
<li><a href="https://www.benzinga.com/quote/ELLXF">Elixinol Wellness</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ELLXF#OTC">ELLXF</a>) shares closed down 46.90% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed down 24.30% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 20.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed down 20.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed down 16.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 15.07% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 10.81% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed down 10.53% at $0.09</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed down 9.09% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/CWBHF">Charlottes Web Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTC">CWBHF</a>) shares closed down 7.43% at $0.08</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed down 7.18% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed down 7.07% at $0.22</li>
<li><a href="https://www.benzinga.com/quote/CPHRF">Cipher Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CPHRF#OTC">CPHRF</a>) shares closed down 4.31% at $9.54</li>
<li><a href="https://www.benzinga.com/quote/GBHPF">Global Hemp Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GBHPF#OTC">GBHPF</a>) shares closed down 4.17% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Global Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed down 3.33% at $0.08</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALEAFIA HEALTH INC ORD by Aleafia Health Inc.

ALEAF

BBRRF

CBDY

CPHRF

CWBHF

ELLXF

FLOOF

GBHPF

GRWG

MRMD

NWVCF

OILFF

SOLCF

TGIFF

XXII

Marijuana Stock Movers For May 12, 2025

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/ELLXF">Elixinol Wellness</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ELLXF#OTC">ELLXF</a>) shares closed up 85.25% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed up 37.04% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed up 25.00% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 25.00% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed up 25.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed up 24.44% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed up 16.39% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed up 14.95% at $0.42</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed up 10.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed up 9.45% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 8.36% at $0.24</li>
<li><a href="https://www.benzinga.com/quote/CWBHF">Charlottes Web Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTC">CWBHF</a>) shares closed up 8.02% at $0.09</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed up 7.73% at $0.04</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/CNGGF">Cann Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNGGF#OTC">CNGGF</a>) shares closed down 65.46% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed down 23.08% at $0.07</li>
<li><a href="https://www.benzinga.com/quote/BLGVF">Belgravia Hartford Cap</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLGVF#OTC">BLGVF</a>) shares closed down 22.41% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed down 16.00% at $1.05</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 13.04% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed down 13.01% at $1.04</li>
<li><a href="https://www.benzinga.com/quote/CRLBF">Cresco Labs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed down 11.53% at $0.73</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">FLUENT</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed down 10.76% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed down 9.57% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CURR">Currenc Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) shares closed down 7.14% at $1.19</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed down 6.21% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/CPHRF">Cipher Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CPHRF#OTC">CPHRF</a>) shares closed down 5.44% at $9.97</li>
<li><a href="https://www.benzinga.com/quote/GTBIF">Green Thumb Indus</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>) shares closed down 4.97% at $5.54</li>
<li><a href="https://www.benzinga.com/quote/BLOZF">Cannabix Technologies</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLOZF#OTC">BLOZF</a>) shares closed down 4.41% at $0.41</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Global Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed down 4.13% at $0.08</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed down 3.75% at $0.10</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 3.46% at $0.43</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed down 3.40% at $0.14</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed down 3.01% at $6.45</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BLGVF

BLOZF

CNGGF

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

CXXIF

GTBIF

ITHUF

LVRLF

Marijuana Stock Movers For May 9, 2025

Germany's <a href="https://www.benzinga.com/topic/germany-cannabis">cannabis landscape</a> continues evolving at a rapid pace. From extensive pharmacy access to a surge in cultivation associations, the country's dual-track model—medical and non-commercial adult use—has turned it into one of the most closely watched cannabis markets in the world.
Still, many in the industry argue that restrictive EU regulations are preventing Germany from reaching its full potential.
<h3 class="wp-block-heading">1 In 7 Pharmacies Now Dispenses Medical Cannabis</h3>
As reported by <a href="https://internationalcbc.com/more-than-1-out-of-every-7-german-pharmacies-offers-medical-cannabis/?utm_source=ICBC+Combined+List+Newsletter+and+Outreach&amp;utm_campaign=7599cd320e-EMAIL_CAMPAIGN_2025_05_05_06_44&amp;utm_medium=email&amp;utm_term=0_-7599cd320e-23726375">ICBC</a>, roughly 2,500 of Germany's 17,000 pharmacies now offer medical cannabis products—a dramatic expansion since legal access began in 2017. Patients can also order cannabis online with a private prescription and have it delivered directly to their homes.
According to the German Cannabis Business Association (BvCW), the country's legal medical cannabis revenue is now estimated at around half a billion euros annually.
Yet that number only scratches the surface of the market's potential. At ICBC Berlin, economist Beau Whitney presented data showing flower and extract sales dominate the German market due to a ban on edibles and other product formats. For comparison, U.S. 4/20 sales were only 41% flower, with the rest divided between vapes, <a href="https://www.benzinga.com/markets/cannabis/25/05/45263739/they-turned-fruit-bouquets-into-a-500m-a-year-businessnow-theyre-selling-thc-heres-why">edibles</a>, <a href="https://www.benzinga.com/markets/cannabis/25/04/44929611/why-pre-rolls-are-cannabis-most-profitable-format-from-california-to-canada">pre-rolls</a> and topicals.
The takeaway? Consumers who prefer smokeless options have limited legal choices in Germany, leaving the door open for the unregulated market.
<h3 class="wp-block-heading">Germany's Cultivation Associations Are Growing Fast</h3>
Meanwhile, the number of licensed cannabis cultivation associations continues to rise. As of early May, Germany had approved 211 of the 624 applications submitted nationwide since the member-based model went live in July 2024.
The associations—legal under EU health policy frameworks—allow registered members to collectively grow cannabis for personal use. Though not commercial in nature, they offer a legal alternative for adults seeking safe, regulated cannabis outside the pharmacy system.
For perspective, Malta—another EU member state with a similar model—has issued 19 permits for its 570,000 residents. Applying Malta's ratio to Germany's population of 84 million implies that over 2,800 associations could eventually be formed.
Still, much remains in flux. Only 25 German applications have been formally rejected so far and many approved groups are still navigating the setup phase.
<h3 class="wp-block-heading">What's Next?</h3>
Germany is already Europe's largest cannabis market, and interest from international operators and policymakers shows no sign of slowing. But experts say broader legalization—including more product categories and commercial access—is essential to meet patient demand and curb illicit activity.
As the BvCW notes, &#8220;the industry's revenue is now estimated at around half a billion euros"—but with edibles, national retail and broader exports still off-limits, the true ceiling remains far higher.
<h3 class="wp-block-heading">Stocks To Watch</h3>
Germany's expanding cannabis market has attracted significant investment from major publicly traded companies. Here are some key players:
<ul>
<li>Tilray Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>): Tilray operates a GMP-certified cultivation facility in Neumünster and has recently expanded its medical cannabis offerings in Germany, including new extract formulations and high-THC flower strains under the Tilray Craft brand.</li>
<li>Aurora Cannabis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>): Aurora launched its first domestically grown medical cannabis brand, IndiMed, cultivated at its EU-GMP facility in Leuna. This move positions Aurora as one of the few companies with local production capabilities in Germany.</li>
<li>Canopy Growth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>): Canopy Growth has introduced its Tweed brand to the German medical cannabis market, expanding its product lineup with new strains through strategic partnerships with EU-based cultivators.</li>
<li>Curaleaf Holdings (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>): Curaleaf has taken a majority stake in Germany&#8217;s Four 20 Pharma, enhancing its footprint in the European market and aiming to leverage Four 20 Pharma&#8217;s distribution network.</li>
<li>High Tide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HITI#NASDAQ">HITI</a>): High Tide initially planned to enter the German medical cannabis market through the acquisition of Purecan GmbH. However, the company is currently reevaluating this strategy and exploring alternative arrangements to establish a presence in Germany.</li>
</ul>
Photo: Shutterstock

Eurozone

HITI

Germany's Cannabis Industry Hits 500 Million Euros: 2,500 Pharmacies Now Dispense, 211 Grow Clubs Approved

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed up 21.95% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed up 18.67% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 13.40% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/OGI">Organigram Global</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) shares closed up 6.26% at $1.10</li>
<li><a href="https://www.benzinga.com/quote/CURR">Currenc Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) shares closed up 4.89% at $1.27</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed up 4.88% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 3.89% at $0.22</li>
<li><a href="https://www.benzinga.com/quote/CWBHF">Charlottes Web Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTC">CWBHF</a>) shares closed up 3.41% at $0.09</li>
<li><a href="https://www.benzinga.com/quote/CBWTF">Auxly Cannabis Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTC">CBWTF</a>) shares closed up 3.33% at $0.06</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/YCBD">cbdMD</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed down 28.86% at $0.13</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 18.03% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed down 11.59% at $6.25</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 11.11% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Global Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed down 9.01% at $0.08</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed down 7.91% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">FLUENT</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed down 6.70% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/CURLF">Curaleaf Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed down 6.33% at $0.87</li>
<li><a href="https://www.benzinga.com/quote/GTBIF">Green Thumb Indus</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>) shares closed down 5.76% at $6.05</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed down 4.91% at $1.19</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 4.69% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/ZDPY">Zoned Properties</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ZDPY#OTC">ZDPY</a>) shares closed down 4.55% at $0.42</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed down 4.29% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed down 4.28% at $4.47</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 3.94% at $0.42</li>
<li><a href="https://www.benzinga.com/quote/CRLBF">Cresco Labs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed down 3.86% at $0.86</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed down 3.66% at $0.16</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed down 3.45% at $1.12</li>
<li><a href="https://www.benzinga.com/quote/IIPR">Innovative Ind Props</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IIPR#NYSE">IIPR</a>) shares closed down 3.16% at $53.00</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

IIPR

ZDPY

Cannabis Stock Gainers And Losers From May 6, 2025

Tilray Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) moved lower on Tuesday following the launch of a timely and tongue-in-cheek offering <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/g45216984/blue-point-brewing-co-announces-the-return-of-delayed-pilsner" rel="noreferrer noopener">from one of its subsidiaries.</a>
Blue Point Brewing Co., a well-known craft beer brand under Tilray&#8217;s beverage umbrella, has announced the return of its Delayed Pilsner — a brew created with New York commuters in mind.
The lager, originally developed as a nod to the all-too-frequent public transportation delays in the city, is once again hitting shelves across the Metro New York area.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/cannabis/25/04/45011379/why-cannabis-stocks-jumped-by-double-digits-and-why-analysts-say-dont-drink-the-kool-aid-in-one-gulp" rel="noreferrer noopener">Why Cannabis Stocks Jumped By Double Digits And Why Analysts Say &#8216;Don&#8217;t Drink The Kool-Aid In One Gulp&#8217;</a>
Carrie Shafir, senior brand director at Tilray Beverages, shared the intention behind the product: &#8220;Delayed Pilsner is our way of helping New Yorkers find a moment of peace amidst the chaos. It&#8217;s a beer that&#8217;s not just refreshing but also comforting.&#8221;
The 16-ounce can features a design inspired by the familiar &#8220;delayed&#8221; signage seen on Penn Station&#8217;s departure boards, particularly referencing Long Island destinations.
It&#8217;s a visual cue that blends humor with an all-too-relatable experience for city residents.
Delayed Pilsner is available in 16oz cans at select retailers and major transit centers across New York.
Tilary Beverages recently launched a new whiskey expression <a target="_blank" href="https://www.benzinga.com/25/04/44963595/whats-going-on-with-tilray-brands-stock-today" rel="noreferrer noopener">under its acclaimed&nbsp;</a><a target="_blank" href="https://www.benzinga.com/25/04/44963595/whats-going-on-with-tilray-brands-stock-today" rel="noreferrer noopener">Breckenridge Distillery</a><a target="_blank" href="https://www.benzinga.com/25/04/44963595/whats-going-on-with-tilray-brands-stock-today" rel="noreferrer noopener">&nbsp;brand.</a>
The distillery unveiled the latest addition to its cask-finished lineup: Breckenridge Cognac Cask Finish Whiskey, which is available in Colorado with broader U.S. distribution anticipated later this year.
Originally released in 2022 as part of the second Collectors Art Series, this limited edition whiskey has returned with an elevated production run.
Price Action: TLRY shares are trading lower by 3.78% to $0.4229 at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/etfs/specialty-etfs/25/05/45229767/pltr-focused-etfs-down-whats-really-behind-palantirs-plunge-the-numbers-dont-tell-the-full-story" target="_blank" rel="noreferrer noopener">PLTR-Focused ETFs Down: What&#8217;s Really Behind Palantir&#8217;s Plunge? The Numbers Don&#8217;t Tell The Full Story</a></li>
</ul>
Photo: Shutterstock

What's Going On With Tilray Brands Stock On Tuesday?

Tilray Brands Craft Beer Brand Blue Point Brewing Re-Releases Delayed Pilsner Beer

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/RSSFF">Affinor Growers</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RSSFF#OTC">RSSFF</a>) shares closed up 30.89% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/LMLLF">Pharmadrug</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed up 28.91% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed up 20.00% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed up 20.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed up 18.89% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 13.34% at $0.23</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed up 12.22% at $1.00</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed up 9.65% at $1.25</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed up 8.51% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/ZDPY">Zoned Properties</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ZDPY#OTC">ZDPY</a>) shares closed up 7.32% at $0.44</li>
<li><a href="https://www.benzinga.com/quote/CURR">Currenc Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) shares closed up 5.37% at $1.41</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Global Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed up 4.44% at $0.09</li>
<li><a href="https://www.benzinga.com/quote/CPHRF">Cipher Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CPHRF#OTC">CPHRF</a>) shares closed up 4.25% at $10.64</li>
<li><a href="https://www.benzinga.com/quote/GTBIF">Green Thumb Indus</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>) shares closed up 3.67% at $6.49</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed up 3.59% at $7.79</li>
<li><a href="https://www.benzinga.com/quote/ESE">ESCO Technologies</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESE#NYSE">ESE</a>) shares closed up 3.42% at $166.78</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed up 3.33% at $0.11</li>
<li><a href="https://www.benzinga.com/quote/SOL">Emeren Group</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed up 3.05% at $1.36</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/ELLXF">Elixinol Wellness</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ELLXF#OTC">ELLXF</a>) shares closed down 34.01% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed down 30.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 23.68% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed down 8.98% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed down 8.33% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed down 6.59% at $0.43</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed down 5.67% at $1.33</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 5.27% at $0.46</li>
<li><a href="https://www.benzinga.com/quote/BLOZF">Cannabix Technologies</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLOZF#OTC">BLOZF</a>) shares closed down 5.16% at $0.41</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed down 4.44% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed down 4.42% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed down 4.17% at $0.71</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed down 4.07% at $0.16</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">FLUENT</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed down 3.57% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed down 3.45% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 3.23% at $0.00</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

LMLLF

RSSFF

Marijuana Stock Movers For May 2, 2025

<a href="https://www.marijuanamoment.net/trumps-pick-to-lead-dea-says-marijuana-rescheduling-review-will-be-one-of-my-first-priorities-in-the-job/" title="https://www.marijuanamoment.net/trumps-pick-to-lead-dea-says-marijuana-rescheduling-review-will-be-one-of-my-first-priorities-in-the-job/">https://www.marijuanamoment.net/trumps-pick-to-lead-dea-says-marijuana-rescheduling-review-will-be-one-of-my-first-priorities-in-the-job/</a>

Biotech

Macro Economic Events

Politics

Economics

AKAN

CRON

IMCC

LFLY

MSOS

SNDL

"Trump's Pick To Lead DEA Says Marijuana Rescheduling Review Will Be 'One Of My First Priorities' In The Job" - Marijuana Moment

Tilray Brands' 10 Barrel Brewing Unveils NA Apocalypse IPA, Offering Bold, Hop-Driven Flavor Without The Alcohol

Author&#8217;s note: this article has been updated to include more context and commentary from analysts.
After months of sluggish performance, <a href="https://www.benzinga.com/cannabis">cannabis stocks</a> finally showed signs of life. This week, the U.S. cannabis sector surged double digits, fueled by new buzz around federal reform and the reemergence of an unlikely political player: Donald Trump.
The rally was led by the AdvisorShares Pure U.S. Cannabis ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSOS#NYSE">MSOS</a>), which jumped roughly 12.5% since Monday. At the time of publication, it had reclaimed its 50-day moving average for the first time since the 2024 election. But whether this move has real legs or is just another hype-fueled head fake depends on what happens next in Washington.
<h2 class="wp-block-heading">The Trump Factor</h2>
According to <a class="" href="https://themarijuanaherald.com/2025/04/president-trump-urging-congress-to-pass-marijuana-banking-bill-before-midterms-say-senate-staffers/">The Marijuana Herald</a>, President Trump is privately urging members of Congress to pass cannabis banking reform before the 2026 midterms. Two senior Senate staffers told the outlet that Trump began contacting lawmakers directly this week, encouraging them to prioritize the <a href="https://www.benzinga.com/topic/safer-banking-act">SAFER Banking Act</a> or similar legislation.
This follows earlier reporting—later confirmed by <a href="https://edition.cnn.com/2025/04/01/politics/trump-marijuana-ads/index.html">CNN</a>—that Trump's team tried to include SAFE banking language in a December 2024 funding resolution. While he hasn't made public comments since retaking office, Trump's campaign previously pledged to support "safe banking for state-authorized companies" and a move to reschedule marijuana for medical research.
No new banking bill has been introduced this session, but members of the Congressional Cannabis Caucus say it remains a top priority.
<h2 class="wp-block-heading">Legislative Winds Picking Up—But Not Moving Markets (Yet)</h2>
The STATES 2.0 Act, a bill that would formally defer cannabis policy to the states and end IRS 280E tax penalties, was reintroduced on April 17. But with no Senate companion and little immediate momentum, the bill didn't appear to influence stock prices. At best, it adds background noise to the growing chorus of reform chatter—but investors are still waiting for action, not aspiration.
<h2 class="wp-block-heading">A Technical Pop And A Cautious Crowd</h2>
"It was a Green Day on Wall Street," wrote Todd Harrison, founder of CB1 Capital, in his <a class="" href="https://substack.com/@toddharrison">Cannabis Confidential</a> newsletter of April 24. "Canna stocks were higher too as talk turned to promises made becoming promises kept."
Still, MSOS remains down 24% year-to-date, a reminder that breakouts in cannabis can fade as fast as they arrive. Harrison echoed that skepticism, noting that "no news is bad news" in a status quo world of "uneven regulations and onerous taxes."
He also referenced a recent White House visit from Weldon Angelos, a longtime advocate for cannabis clemency and reform, suggesting behind-the-scenes efforts are ramping up: "Suffice to say that if I was already of the view that promises made will be promises kept—I was—I feel better today than I did yesterday, despite still not having a line-of-sight on the timing."
Even so, he cautioned that many U.S. operators are still "racing against the clock" as tangible solutions to well-known issues—like tax burdens, banking access, custody restrictions and debt refinancing—remain elusive. 
"Tangible problems require tangible solutions, which are apparently on the way… but financial activity—restructurings, M&amp;A, equity movement—has largely ground to a halt."
<h2 class="wp-block-heading">Analysts Say Don't Chase It Just Yet</h2>
Viridian Capital Advisors struck a similar tone. In a client note, the firm acknowledged the optimism but warned against over-committing to rumors.
"Until Trump publicly states his support for SAFE banking and makes it more concrete than ‘before the midterms,' investors are right not to overcommit."
Viridian's analysis of U.S. MSOs with market caps between $50 million and $200 million shows the group still trades at a median EV/2025 EBITDA multiple of 4.57x, or 6.14x, when adjusted for lease and tax obligations. That signals potential value, but only if the policy tailwinds materialize.
"Recent news is causing some long-lost optimism," Viridian added. "Just don't drink all of the Kool-Aid in one gulp. Maintain dry powder to fill in positions on pullbacks."
<h2 class="wp-block-heading">Cannabis Stocks On The Move</h2>
Here&#8217;s how key cannabis stocks have performed this week so far:
<ul>
<li>Green Thumb Industries Inc (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>): up almost 11%</li>
<li>Trulieve Cannabis Corp (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>): up almost 29%</li>
<li>Curaleaf Holdings Inc (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>): up 6.2%</li>
<li>Cronos Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRON#NASDAQ">CRON</a>): up 5.4%</li>
<li>Tilray Brands Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>): up 11%</li>
<li>Canopy Growth Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>): up 34.3%</li>
<li>SNDL Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>): up 7.5%</li>
<li>Glass House Brands Inc (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GLASF#OTC">GLASF</a>): up 14.5%</li>
</ul>
<h2 class="wp-block-heading">The Bottom Line</h2>
Cannabis stocks rallied. Sentiment improved. Technicals woke up. But in this sector, headlines come cheap and real reform still costs political capital.
If SAFE banking re-emerges and Trump goes public with his support, this week's bounce could turn into something more meaningful. But until then, this may be just another puff of smoke in the long saga of cannabis policy and price action.
Photo: Shuttertock

Trading Ideas

GLASF

Why Cannabis Stocks Jumped By Double Digits And Why Analysts Say 'Don't Drink The Kool-Aid In One Gulp'

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed up 138.10% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed up 41.36% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed up 36.62% at $0.11</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed up 22.50% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed up 20.33% at $4.67</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed up 20.17% at $1.49</li>
<li><a href="https://www.benzinga.com/quote/CRLBF">Cresco Labs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed up 18.63% at $0.78</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed up 18.06% at $0.17</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed up 17.33% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/GTBIF">Green Thumb Indus</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>) shares closed up 16.57% at $6.19</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 14.10% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed up 12.99% at $8.35</li>
<li><a href="https://www.benzinga.com/quote/ZDPY">Zoned Properties</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ZDPY#OTC">ZDPY</a>) shares closed up 12.83% at $0.42</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed up 11.74% at $0.49</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed up 9.14% at $0.10</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed up 8.47% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">FLUENT</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed up 7.78% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed up 7.33% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/CURLF">Curaleaf Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed up 7.26% at $0.97</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 6.81% at $0.20</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed up 6.74% at $0.99</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed up 6.67% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/ACB">Aurora Cannabis</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares closed up 6.45% at $4.71</li>
<li><a href="https://www.benzinga.com/quote/YCBD">cbdMD</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed up 6.29% at $0.26</li>
<li><a href="https://www.benzinga.com/quote/OGI">Organigram Global</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) shares closed up 5.56% at $1.16</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed up 5.43% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed up 5.26% at $0.49</li>
<li><a href="https://www.benzinga.com/quote/SNDL">SNDL</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) shares closed up 4.92% at $1.48</li>
<li><a href="https://www.benzinga.com/quote/CPHRF">Cipher Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CPHRF#OTC">CPHRF</a>) shares closed up 4.50% at $8.65</li>
<li><a href="https://www.benzinga.com/quote/SOL">Emeren Group</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed up 3.97% at $1.31</li>
<li><a href="https://www.benzinga.com/quote/CRON">Cronos Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRON#NASDAQ">CRON</a>) shares closed up 3.35% at $1.85</li>
<li><a href="https://www.benzinga.com/quote/IIPR">Innovative Ind Props</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IIPR#NYSE">IIPR</a>) shares closed up 3.09% at $53.38</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 93.81% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed down 11.81% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed down 9.17% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed down 4.60% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/GBHPF">Global Hemp Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GBHPF#OTC">GBHPF</a>) shares closed down 4.17% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Global Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed down 3.33% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed down 3.15% at $0.80</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cannabis Stock Movers For April 24, 2025

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed up 17.55% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed up 15.99% at $7.39</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed up 9.19% at $0.83</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed up 8.30% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed up 7.24% at $0.08</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed up 5.08% at $1.24</li>
<li><a href="https://www.benzinga.com/quote/SOL">Emeren Group</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed up 4.79% at $1.26</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed up 4.35% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed up 4.17% at $0.93</li>
<li><a href="https://www.benzinga.com/quote/OGI">Organigram Global</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) shares closed up 3.77% at $1.08</li>
<li><a href="https://www.benzinga.com/quote/ACB">Aurora Cannabis</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares closed up 3.29% at $4.40</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/ALEAF">Aleafia Health</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ALEAF#OTC">ALEAF</a>) shares closed down 99.00% at $1e-06</li>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed down 40.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/ELLXF">Elixinol Wellness</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ELLXF#OTC">ELLXF</a>) shares closed down 35.48% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed down 28.57% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed down 22.37% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed down 22.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 20.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/MGWFF">Maple Leaf Green World</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MGWFF#OTC">MGWFF</a>) shares closed down 17.81% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 8.54% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed down 5.53% at $0.61</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed down 5.15% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/ZDPY">Zoned Properties</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ZDPY#OTC">ZDPY</a>) shares closed down 4.55% at $0.37</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 3.84% at $0.44</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed down 3.25% at $0.01</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MGWFF

Bearish Sentiment Across The Cannabis Space - Check Full Movers For April 23, 2025

Tilray Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) launched a new whiskey expression under its acclaimed <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/g44945150/breckenridge-distillery-announces-re-release-of-award-winning-cognac-cask-finish-whiskey" rel="noreferrer noopener">Breckenridge Distillery</a><a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/g44945150/breckenridge-distillery-announces-re-release-of-award-winning-cognac-cask-finish-whiskey" rel="noreferrer noopener"> brand on Wednesday</a>.
The distillery unveiled the latest addition to its cask-finished lineup: Breckenridge Cognac Cask Finish Whiskey, which is available in Colorado with broader U.S. distribution anticipated later this year.
Originally released in 2022 as part of the second Collectors Art Series, this limited edition whiskey has returned with an elevated production run.
The label design honors its French barrel origins, featuring the iris—the national flower of France—and grape blossoms to acknowledge the Cognac region's heritage.
Bryan Nolt, founder and CEO of Breckenridge Distillery, emphasized the product's role in the company's innovation journey: "Our Cognac Cask Finish is a testament to our dedication to innovation and quality."
The new release will retail for $59.99.
Also Read: <a target="_blank" href="https://www.benzinga.com/government/regulations/25/04/44952395/us-business-activity-growth-slows-in-april-as-services-suffer-tariff-shock-markets-rally-as-trade-war-cools" rel="noreferrer noopener">Business Growth Cools, Prices Rise, And Markets Surge On Tariff Rollback Hopes</a>
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, TLRY stock has lost over 75% in the past year. Investors can gain exposure to the stock via&nbsp;AdvisorShares Pure Cannabis ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YOLO#NYSE">YOLO</a>).
Earlier in April, the company announced plans to<a target="_blank" href="https://www.benzinga.com/news/25/04/44876284/tilray-stock-hit-a-new-52-week-low-today-whats-going-on" rel="noreferrer noopener">&nbsp;implement a reverse stock split.</a>
The move, subject to shareholder approval at a June 10 special meeting, proposes a split ratio between 1-for-10 and 1-for-20. This corporate action is aimed at boosting the per-share price and maintaining compliance with Nasdaq&#8217;s minimum listing requirements.
CEO&nbsp;Irwin Simon&nbsp;said the&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/g44859783/tilray-brands-announces-proposed-reverse-stock-split-and-corresponding-special-meeting-of-stockhol" rel="noreferrer noopener">reverse split</a>&nbsp;will better align Tilray&#8217;s share count with peers and help stabilize trading. While the fundamentals remain intact, reverse splits are often perceived negatively by investors, as they can signal financial struggles or weak stock performance.
Price Action: TLRY shares are trading lower by 2.12% to %0.4482&nbsp;at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44948932/goldman-sachs-backs-copper-tariff-trade-if-trump-slaps-25-duty-on-us-imports" target="_blank" rel="noreferrer noopener">Goldman Sachs Backs ‘Copper Tariff Trade' If Trump Slaps 25% Duty On US Imports</a></li>
</ul>
Photo: Shutterstock

What's Going On With Tilray Brands Stock Today?

Tilray's Breckenridge Distillery Unveils Cognac Cask Finish Whiskey, Plans U.S. Expansion

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 36.99% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/ELLXF">Elixinol Wellness</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ELLXF#OTC">ELLXF</a>) shares closed up 23.33% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed up 20.10% at $0.10</li>
<li><a href="https://www.benzinga.com/quote/CURLF">Curaleaf Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed up 16.33% at $0.98</li>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed up 12.50% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CRLBF">Cresco Labs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed up 8.74% at $0.67</li>
<li><a href="https://www.benzinga.com/quote/GTBIF">Green Thumb Indus</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>) shares closed up 7.69% at $5.60</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed up 4.92% at $0.16</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed up 4.74% at $52.17</li>
<li><a href="https://www.benzinga.com/quote/CURR">Currenc Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) shares closed up 4.66% at $1.54</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Glb Inv</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed up 4.43% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/SOL">Emeren Group</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed up 4.24% at $1.26</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed up 3.85% at $0.91</li>
<li><a href="https://www.benzinga.com/quote/SNDL">SNDL</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) shares closed up 3.70% at $1.40</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed up 3.45% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed up 3.39% at $1.19</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed up 3.39% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/BLOZF">Cannabix Technologies</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLOZF#OTC">BLOZF</a>) shares closed up 3.38% at $0.46</li>
<li><a href="https://www.benzinga.com/quote/ACB">Aurora Cannabis</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares closed up 3.21% at $4.44</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed down 73.33% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed down 46.39% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed down 10.63% at $0.57</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed down 7.19% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed down 6.17% at $0.17</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed down 4.91% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">FLUENT</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed down 4.68% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed down 4.67% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 4.60% at $0.45</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed down 3.75% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed down 3.72% at $6.03</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Marijuana Stock Movers For April 18, 2025

From the halls of Congress to the streets of New York, cannabis news bloomed in every direction this week. Slovenia introduced what may become Europe's most progressive medical cannabis law. U.S. lawmakers filed new federal reform legislation. Trulieve and Curaleaf took diverging paths in Florida. And Governor Ron DeSantis faces questions over whether public funds were funneled into anti-cannabis campaigns.
Elsewhere, Weedmaps dropped a custom sneaker collab, Swatch&#8217;s 4/20-friendly watch returned to the spotlight and a massive new cancer study delivered groundbreaking validation for medical cannabis. Avicanna posted record earnings, Minnesota crossed a regulatory milestone and Blue Violets made delivery history in New Jersey.
Here's everything you need to know.
<h3 class="wp-block-heading">Business And Financial Moves</h3>
Avicanna Reports Record Year
Avicanna Inc. (TSX:<a class="ticker" href="https://www.benzinga.com/stock/AVCN#TSX">AVCN</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/AVCNF#OTCQX">AVCNF</a>) reported audited financial results for 2024, including $25.5 million in revenue—a 52% increase over 2023—and gross profits of $12.9 million, up 94%. Consolidated gross margins improved to 51%, while adjusted EBITDA losses narrowed by 68% to $1.4 million. The company also repaid $1.3 million in debt.
CEO Aras Azadian called 2024 "our most successful year to date," citing clinical innovation, international expansion, and commercial growth in Canada and abroad.
Key 2024 milestones include:
<ul>
<li>A real-world evidence study in Canada evaluating cannabis for conditions like pain, sleep, anxiety and epilepsy</li>
<li>A completed study at The Hospital for Sick Children assessing CBD topical creams for wound healing</li>
<li>Drug approval in Colombia for Trunerox, targeting rare epileptic disorders</li>
<li>First delivery of CBD/CBG topicals to a multinational pharmaceutical company</li>
<li>Two new U.S. patents for topical and oral cannabinoid delivery technologies</li>
</ul>
<a href="https://www.benzinga.com/news/earnings/25/04/44802163/why-cannabis-focused-biopharma-co-avicanna-traded-up-26-today">Read the full story here</a>.
Tilray Plans Reverse Stock Split
Tilray Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) will hold a special shareholder meeting on June 10 to vote on a proposed reverse stock split ranging from 1-for-10 to 1-for-20. CEO Irwin Simon said the move aims to maintain Nasdaq compliance, reduce costs by more than $1 million per year, and attract institutional investors. The company recently reported over $248 million in cash and trimmed debt by $76 million.
<a href="https://www.benzinga.com/markets/cannabis/25/04/44871447/why-cannabis-co-tilray-tlry-is-trading-down-today">Read more on Benzinga</a>
Safe Harbor and FundCanna Join Forces
SHF Holdings, d/b/a Safe Harbor Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHFS#NASDAQ">SHFS</a>), announced a strategic partnership with FundCanna to provide cannabis operators with streamlined access to capital and compliant banking services. The agreement enables mutual referrals and onboarding of FundCanna-approved clients into Safe Harbor-managed accounts.
"This partnership delivers a practical, scalable solution that puts the financial needs of cannabis operators first," said Safe Harbor CEO Terry Mendez.
<h3 class="wp-block-heading">Politics, Policy And Regulation</h3>
Congress Reintroduces STATES 2.0 Act
A bipartisan group of U.S. lawmakers reintroduced the STATES 2.0 Act, which would shield legal cannabis activity from federal interference. The bill would also legalize interstate commerce, normalize IRS treatment of cannabis businesses and establish a framework for federal oversight and testing.
"The current federal approach to cannabis policy is not working," said Rep. Dave Joyce (R-OH), co-chair of the Congressional Cannabis Caucus. "The STATES 2.0 Act creates a more logical approach that protects states' rights while improving public safety."
The bill maintains FDA oversight for cannabis products, removes barriers to tax deductions under Section 280E, and instructs federal agencies to begin rulemaking within 180 days of passage. Supporters include Reps. Max Miller (R-OH), Dina Titus (D-NV) and a coalition of advocacy organizations including CPEAR, Americans for Prosperity, and the U.S. Cannabis Roundtable.
<a class="" href="https://www.marijuanamoment.net">Read more via Marijuana Moment</a>
Minnesota Finalizes Adult-Use Cannabis Rules
The Minnesota Office of Cannabis Management (OCM) announced that final adult-use rules were published in the State Register and are now in effect. With this step completed, OCM can begin issuing business licenses to qualifying applicants, including more than 600 social equity applicants already advanced through preapproval.
"We are continuing to prioritize social equity in every stage of licensing," said Jess Jackson, OCM's director of social equity. Licenses for capped categories such as cultivator and retailer will be awarded via lottery later this summer, while uncapped license types will be distributed on a rolling basis.
<a class="" href="https://cannabis.mn.gov">Details available on the OCM Rulemaking page</a>
Slovenia Unveils Progressive Medical Cannabis Law
Slovenia's Parliament introduced sweeping medical cannabis reforms that would legalize the cultivation, production and distribution of cannabis for medical and scientific use. The bill eliminates public tenders, allows open licensing for private companies and removes cannabis and THC from the country's prohibited drugs list—so long as products meet GACP, GMP and European Pharmacopeia standards.
Cannabis will be available via standard medical or veterinary prescriptions, and patient access is guaranteed through pharmacies, licensed distributors and healthcare providers.
The legislation follows a 2024 referendum in which 66.7% of voters supported cannabis cultivation and legalization for medical use. According to ICBC, the new framework would position Slovenia as having the most advanced medical cannabis law in Europe.
<a class="" href="https://internationalcbc.com/slovenian-parliament-introduces-europes-most-progressive-medical-cannabis-law">Full article via ICBC</a>
DeSantis Faces Scrutiny Over Anti-Cannabis Funding
A Miami Herald investigation revealed that the DeSantis administration steered $10 million from a legal Medicaid settlement to a charity led by Florida First Lady Casey DeSantis. That charity then gave $5 million each to two organizations backing a political committee that opposed Amendment 3, the failed 2024 initiative to legalize adult-use cannabis in Florida.
The money flowed from the Hope Florida Foundation to Secure Florida's Future and Save Our Society from Drugs, which then routed millions to Keep Florida Clean, a DeSantis-aligned committee. Republican lawmakers are now demanding records and investigating whether public funds were improperly used to fight cannabis legalization.
<a class="" href="https://www.miamiherald.com/news/politics-government/article304020886.html">Full investigation by the Miami Herald</a>
<h3 class="wp-block-heading">State Moves And Brand Power Plays</h3>
Carmelo Anthony Launches STAYME7O In New York
Carmelo Anthony has entered the New York cannabis market with STAYME7O, a premium cannabis brand launched in partnership with Grand National, the creative agency he co-founded with Jesce Horton and Brandon Drew Jordan Pierce. The product line features curated flower cultivated by Oregon-based LOWD, with an emphasis on sustainability and unique genetics.
"This isn't just about cannabis—it's about empowering our communities," Anthony said. A portion of proceeds will support NuProject and the Last Prisoner Project, continuing the brand's focus on economic equity and justice reform.
<a class="" href="https://www.benzinga.com/general/sports/25/04/44801792/carmelo-anthony-enters-new-york-cannabis-market-all-about-his-product-line-and-creative-agency">Full story on Benzinga</a>
Curaleaf Turns Dispensary Into Hemp Shop
Curaleaf (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) has converted one of its medical dispensaries in West Palm Beach into a hemp-focused retail store called The Hemp Company. The location will offer Farm Bill-compliant THC products from Curaleaf brands and partners like 1906 and Cann.
The move comes as Curaleaf distances itself from Florida's stalled adult-use push and signals short-term interest in the rapidly growing hemp-derived THC segment.
Trulieve Invests $19.6M To Revive Legalization Push
Trulieve (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) contributed $19.6 million to Smart &amp; Safe Florida to support another attempt at adult-use legalization in 2026. That's in addition to the $145 million the company spent on the failed 2024 initiative.
So far, only 150,804 signatures have been verified out of the 880,062 needed to qualify for the next ballot, raising questions about whether other operators will step in to help fund the campaign.
Herbwell Cannabis Targets Manhattan's Elite
Herbwell, a national cannabis chain, is opening a luxury dispensary at 519 Madison Avenue—possibly the only one of its kind on the high-end Manhattan corridor. The shop promises a curated experience for both seasoned users and curious first-timers.
"We've built a gorgeous dispensary that fits in on Madison Avenue," said CEO Arish Halani. "One day we'll be doing collabs with the biggest brands in the world."
The brand is also planning to open a cannabis club in the building's upper floors, including a rooftop lounge overlooking Midtown, pending future regulations.
New Jersey's First E-Bike Weed Delivery
Hoboken dispensary Blue Violets has launched New Jersey's first cannabis delivery service by e-bike, in partnership with delivery tech company Priscotty. The program is live in Hoboken and parts of Jersey City and Weehawken.
"We want to reach our customers when they can't make their way to the store—but in a way that makes sense," said Lauren Thompson, co-owner of Blue Violets.
<h3 class="wp-block-heading">Culture And Commentary</h3>
Mike Tyson Becomes CEO Of Carma HoldCo
Boxing legend Mike Tyson has taken the reins as CEO of Carma HoldCo, the company behind TYSON 2.0, Ric Flair Drip, Evol by Future and Wooooo! Energy. The move marks Tyson's shift from brand ambassador to active executive, steering a portfolio built on cultural storytelling and celebrity power.
"This isn't just a title—it's a responsibility I take seriously," Tyson said. Under his leadership, Carma plans to double down on authenticity, community engagement and global expansion.
<a class="" href="https://www.benzinga.com/markets/cannabis/25/04/44871633/mike-tyson-cannabis-ceo-the-champ-now-runs-carma-holdco">Read the full story on Benzinga</a>
Weedmaps Drops 420 1's Sneaker Collab With CEEZE
In one of the most buzzworthy 4/20 drops of the year, Weedmaps and custom sneaker studio CEEZE released the limited-edition "420 1's." Each of the 420 pairs is individually numbered, housed in an acrylic box with LED lighting and linked to a microsite via QR code.
The Friends &amp; Family version even includes GPS coordinates pointing to the historic San Francisco Cannabis Buyers Club. A sweepstakes is running through April 20, offering 20 pairs and one VIP trip to Spannabis.
<a class="" href="https://weedmaps.com/wm-sneakers-420-1s">Details and entry here</a>
Swatch's 4/20 Watch Gets a Second Life
Swatch's "Up In Smoke" watch from 2024 has found new life this April. With minty green hues, smoke-dial graphics and a laid-back BIOCERAMIC case, the piece fits right into the 4/20 aesthetic. Originally part of the BIG BOLD collection, the watch has quietly become a seasonal flex for cannabis aficionados.
<a class="" href="https://www.benzinga.com/markets/cannabis/25/04/44878425/swatchs-up-in-smoke-watch-is-the-low-key-flex-of-4-20-season">Read the full feature on Benzinga</a>
Dreka Gates, Tiffany Haddish And Chamath Sound Off
Cannabis was also front and center in this week's cultural commentary. Highlights include:
<ul>
<li>Dreka Gates, in an exclusive interview, said: "Cannabis would be a trillion-dollar industry for Black and Brown communities—if it hadn't been criminalized." <a class="" href="https://www.benzinga.com/markets/cannabis/25/04/39798605/dreka-gates-cannabis-would-be-a-trillion-dollar-industry-for-black-and-brown-communities-if-it-h">Read more</a></li>
<li>Tiffany Haddish remarked that "If men had period pain, weed would already be legal." <a class="" href="https://www.benzinga.com/markets/cannabis/25/04/39797136/tiffany-haddish-if-men-had-period-pain-weed-would-already-be-legal">Full story here</a></li>
<li>Chamath Palihapitiya criticized the industry, saying legalization "turned our kids into zombies." <a class="" href="https://www.benzinga.com/general/health-care/25/04/44831042/chamath-palihapitiya-calls-for-mandate-on-insidious-marijuana-labelling-and-toxicity-says-its-turning-kids-into-zombies">His take here</a></li>
</ul>
<h3 class="wp-block-heading">Science And Health</h3>
Landmark Study Confirms Cannabis Benefits for Cancer Patients
In what may be the most comprehensive review of its kind, Cancer Playbook and the Whole Health Oncology Institute published a meta-analysis of over 10,000 peer-reviewed studies on medical cannabis and cancer. The result: a 3-to-1 scientific consensus in favor of cannabis for treating cancer-related symptoms, including inflammation, metastasis, appetite loss and pain.
"We expected controversy. What we found was overwhelming scientific consensus," said Ryan Castle, WHOI's head of research.
The study also incorporated patient-reported outcomes to highlight real-world effectiveness—marking a shift toward more holistic, experience-driven research models. Findings from this report were submitted to the DEA as part of the case for rescheduling cannabis.
<a class="" href="https://www.benzinga.com/general/health-care/25/04/44835610/game-changing-study-confirms-medical-cannabis-helps-cancer-patients-we-found-overwhelming-scientific-consensus">Link to the full Benzinga article</a>
Israel Slaps 165% Tariffs on Canadian Cannabis
In a dramatic turn, Israel's Ministry of Economy announced it will impose tariffs of up to 165% on Canadian cannabis imports for the next four years. The decision—pending approval by the Knesset Finance Committee—carves out exceptions for select producers like Decibel (12%), Village Farms (28%), Organigram (53%) and Tilray (70%).
The move signals a potential realignment of the global cannabis trade, with implications for both exporters and Israeli medical patients.
<a class="" href="https://stratcann.com">More via StratCann</a>
<h3 class="wp-block-heading">Recommended Reads</h3>
<ul>
<li><a class="" href="https://www.forbes.com/sites/javierhasse/2025/04/14/he-sold-his-cannabis-vape-brand-for-nine-figures-now-hes-coming-for-your-cocktail/">He Sold His Cannabis Vape Brand for Nine Figures—Now He's Coming for Your Cocktail</a></li>
<li><a class="" href="https://www.benzinga.com/markets/cannabis/25/04/44818968/how-one-european-company-is-flooding-america-with-cannabis-seeds">How One European Company Is Flooding America With Cannabis Seeds</a></li>
</ul>
That&#8217;s it for this week. See you next Friday!

Earnings

AVCNF

SHF Holdings, Inc. - Class A Common Stock

SHFS

TSX:AVCN

This Week In Cannabis: Carmelo's NY Launch, Federal Reform, Cancer Study, Avicanna's Growth, Tilray's Split, DeSantis Fallout, Slovenia's Big Move And More

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 36.99% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/ELLXF">Elixinol Wellness</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ELLXF#OTC">ELLXF</a>) shares closed up 23.33% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed up 20.10% at $0.10</li>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed up 12.50% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed up 11.21% at $3.87</li>
<li><a href="https://www.benzinga.com/quote/CRLBF">Cresco Labs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed up 8.74% at $0.67</li>
<li><a href="https://www.benzinga.com/quote/GTBIF">Green Thumb Indus</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>) shares closed up 7.69% at $5.60</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed up 5.63% at $0.23</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed up 4.92% at $0.16</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed up 4.74% at $52.17</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Glb Inv</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed up 4.43% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed up 3.85% at $0.91</li>
<li><a href="https://www.benzinga.com/quote/SNDL">SNDL</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) shares closed up 3.70% at $1.40</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed up 3.45% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed up 3.39% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/BLOZF">Cannabix Technologies</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLOZF#OTC">BLOZF</a>) shares closed up 3.38% at $0.46</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed down 73.33% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed down 46.39% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed down 8.70% at $0.57</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed down 7.19% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed down 6.17% at $0.17</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 5.11% at $0.45</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed down 4.91% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">FLUENT</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed down 4.68% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed down 4.67% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed down 3.82% at $0.58</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed down 3.75% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed down 3.72% at $6.03</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cannabis Stock Movers For April 17, 2025

Press Releases

Tilray Medical Introduces Cannabis Edibles in Australia

Tilray Beverages Launches Cruisies, a New Line of Ready-To-Drink Cocktails

Breckenridge Distillery Announces Re-Release of Award-Winning Cognac Cask Finish Whiskey

Terrapin Beer Co. Celebrates 23 Years of Craft Beer and Environmental Stewardship with Terraprint Initiative and Orvis Partnership

Opinion

Forget Sugary Sodas Wellness Drinks Are Gaining Ground With Consumers and Investors

Restaurants

Widmer Brothers Brewing Celebrates 40th Anniversary

10 Barrel Brewing Launches Non-Alcoholic Apocalypse IPA, a Bold Craft Brew for Your Next Adventure

Blue Point Brewing Co. Announces the Return of Delayed Pilsner

Shock Top: A Bold Rebrand for a Craft Beer Icon

Tilray Brands Announces the Launch of XMG Atomic Sours: New THC Beverages and Edibles

Comments

Tilray Brands

ニュース

最新ニュース Tilray Brands (NASDAQ:TLRY) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル